Tamiflu
NDC 0004-0822, Oseltamivir Phosphate, powder, for suspension, from Genentech, Inc..
- Product NDC
- 0004-0822
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021246
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0004-0822 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OSELTAMIVIR PHOSPHATE6 mg/mL
Pharmacologic classes
Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0004-0822-05 | 00004082205 | 1 BOTTLE, GLASS in 1 CARTON (0004-0822-05) / 60 mL in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ee3c9555-60f2-4f82-a760-11983c86e97bNADAC price for package 00004082205
GET /v1/drugs/nadac/00004082205
Use it
Look up 0004-0822 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0004-0822 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0004-0822. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.